MEETING ABSTRACT Open Access Allergen immunotherapy

the clinical symptoms associated with allergic rhinitis, asthma and venom induced anaphylaxis [1]. Subcuta-neous (SCIT) and Sublingual (SLIT) with unmodified allergen extracts are the two routes of administration of allergen vaccines. In addition, AIT has been positioned as the only treat-ment that may alter the natural course of allergic disease [2]. However both SCIT and SLIT require that the treat-ment is taken regularly over several years e.g. monthly in a supervised medical setting with SCIT and at lowest three times a week with SLIT. Emerging evidence sug-gests that specific allergen immunotherapy may be effec-tive in other allergic conditions such as IgE mediated food allergy [3,4] and extrinsic form IgE mediated Atopic Dermatitis [5]. On all these fields, the immunotherapy’